Advertisement

Liver Diseases pp 673-678 | Cite as

Ablation of Hepatocellular Carcinoma

  • Lukas BeyerEmail author
  • Lukas Luerken
Chapter

Abstract

Ablation is an effective alternative to resection for very early and early stages of hepatocellular carcinoma (HCC) according to the criteria of the Barcelona Clinic Liver Cancer Staging System. There is a wide range of ablation techniques, including mono- and multipolar radiofrequency ablation, microwave ablation and irreversible electroporation. In contrast to the other techniques, irreversible electroporation is not temperature-based and can therefore be used in the vicinity of large bile ducts and vessels. For HCC larger than 3 cm, ablation should be combined with transarterial chemoembolization. In recent years, technical developments have contributed to the efficient and curative treatment of at-risk-location and large HCCs, which were previously regarded as “non-ablatable”. Percutaneous ablation can also be successfully used as a bridging technique for liver transplant patients.

Keywords

HCC Liver metastasis Interventional oncology Ablation 

References

  1. 1.
    Goldberg SN, Gazelle GS, Dawson SL, Rittman WJ, Mueller PR, Rosenthal DI. Tissue ablation with radiofrequency: effect of probe size, gauge, duration, and temperature on lesion volume. Acad Radiol. 1995;2(5):399–404.CrossRefGoogle Scholar
  2. 2.
    Lewin JS, Connell CF, Duerk JL, Chung YC, Clampitt ME, Spisak J, Gazelle GS, Haaga JR. Interactive MRI-guided radiofrequency interstitial thermal ablation of abdominal tumors: clinical trial for evaluation of safety and feasibility. J Magn Reson Imaging. 1998;8(1):40–7.CrossRefGoogle Scholar
  3. 3.
    Hosten N, Puls R, Kreissig R, Wlodarczyk W, Stroszczynski C, Hentschel M, Felix R. In vivo temperature measurements and MR-thermometry during laser-induced interstitial thermotherapy (LITT) of liver metastasis. Eur Radiol. 2000;10(Suppl 1)Google Scholar
  4. 4.
    Vogl TJ, Mueller PK, Hammerstingl R, Weinhold N, Mack MG, Philipp C, Deimling M, Beuthan J, Pegios W, Riess H, Felix R. Malignant liver tumors treated with MR imaging-guided laser-induced thermotherapy: technique and prospective results. Radiology. 1995;196:257–65.CrossRefGoogle Scholar
  5. 5.
    Curley SA, Izzo F. Radiofrequency ablation of primary and metastatic hepatic malignancies. Int J Clin Oncol. 2002;7(2):72–81.CrossRefGoogle Scholar
  6. 6.
    Al-Sakere B, Andre F, Bernat C, et al. Tumor ablation with irreversible electroporation. PLoS One. 2007;2(11):e1135.CrossRefGoogle Scholar
  7. 7.
    European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182. https://www.sciencedirect.com/science/article/pii/S0168827818302150. Accessed January 31, 2019.CrossRefGoogle Scholar
  8. 8.
    Roayaie S, Obeidat K, Sposito C, Mariani L, Bhoori S, Pellegrinelli A, et al. Resection of hepatocellular cancer ≤2 cm: results from two Western centers. Hepatology. 2013;57:1426–35.CrossRefGoogle Scholar
  9. 9.
    Cucchetti A, Piscaglia F, Cescon M, Colecchia A, Ercolani G, Bolondi L, et al. Cost-effectiveness of hepatic resection vs. percutaneous radiofrequency ablation for early hepatocellular carcinoma. J Hepatol. 2013;59:300–7.CrossRefGoogle Scholar
  10. 10.
    Forner A, Reig ME, de Lope CR, Bruix J. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis. 2010;30:61–74.CrossRefGoogle Scholar
  11. 11.
    Majumdar A. Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis. Cochrane Database Syst Rev. 2017;3:CD011650.PubMedGoogle Scholar
  12. 12.
    Kang TW, Lim HK, Lee MW, Kim Y, Rhim H, Lee WJ, et al. Long-term therapeutic outcomes of radiofrequency ablation for subcapsular vs. nonsubcapsular hepatocellular carcinoma: a propensity score matched study. Radiology. 2016;280:300–12.CrossRefGoogle Scholar
  13. 13.
    Harari CM, Magagna M, Bedoya M, Lee FT Jr, Lubner MG, Hinshaw JL, et al. Microwave ablation: comparison of simultaneous and sequential activation of multiple antennas in liver model systems. Radiology. 2016;278(1):95–103.CrossRefGoogle Scholar
  14. 14.
    Beyer LP, et al. Stereotactically navigated percutaneous microwave ablation (MWA) compared to conventional MWA: a matched pair analysis. Int J Comput Assist Radiol Surg. 2018;13(12):1991.CrossRefGoogle Scholar
  15. 15.
    Yang D-J, Luo K-L, Liu H, Cai B, Tao G-Q, Su X-F, et al. Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma. Oncotarget. 2017;8(2):2960–70.PubMedGoogle Scholar
  16. 16.
    Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer. 2000;88(11):2452–63.CrossRefGoogle Scholar
  17. 17.
    Goldberg SN, Gazelle GS, Solbiati L, Rittman WJ, Mueller PR. Radiofrequency tissue ablation: increased lesion diameter with a perfusion electrode. Acad Radiol. 1996;3(8):636–44.CrossRefGoogle Scholar
  18. 18.
    Lubner MG, Brace CL, Hinshaw JL, Lee FT Jr. Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol. 2010;21(8 Suppl):S192–203.CrossRefGoogle Scholar
  19. 19.
    Brace CL. Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences? Curr Probl Diagn Radiol. 2009;38(3):135–43.CrossRefGoogle Scholar
  20. 20.
    Abdelaziz A, Elbaz T, Shousha HI, Mahmoud S, Ibrahim M, Abdelmaksoud A, Nabeel M. Efficacy and survival analysis of percutaneous radiofrequency versus microwave ablation for hepatocellular carcinoma: an Egyptian multidisciplinary clinic experience. Surg Endosc. 2014;28(12):3429.CrossRefGoogle Scholar
  21. 21.
    Lu MD, Xu HX, Xie XY, Yin XY, Chen JW, Kuang M, Xu ZF, Liu GJ, Zheng YL. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study. J Gastroenterol. 2005;40(11):1054.CrossRefGoogle Scholar
  22. 22.
    Facciorusso A, Di Maso M, Muscatiello N. Microwave ablation vs. radiofrequency ablation for the treatment of hepatocellular carcinoma: a systematic review and meta-analysis. Int J Hyperthermia. 2016;32:339–44.CrossRefGoogle Scholar
  23. 23.
    Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J. 1982;1(7):841–5.CrossRefGoogle Scholar
  24. 24.
    Weaver JC, Chizmadzhev YA. Theory of electroporation: a review. Bioelectrochem Bioenerg. 1996;41(2):135–60.  https://doi.org/10.1016/S0302-4598(96)05062-3.CrossRefGoogle Scholar
  25. 25.
    Lee EW, Chen C, Prieto VE, Dry SM, Loh CT, Kee ST. Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation. Radiology. 2010;255(2):426–33.  https://doi.org/10.1148/radiol.10090337.CrossRefPubMedGoogle Scholar
  26. 26.
    Al-Sakere B, André F, Bernat C, et al. Tumor ablation with irreversible electroporation. PLoS One. 2007;2(11):e1135.  https://doi.org/10.1371/journal.pone.0001135.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Yeung ES, Chung MW, Wong K, Wong CY, So EC, Chan AC. An update on irreversible electroporation of liver tumours. Hong Kong Med J. 2014;20(4):313–6.PubMedGoogle Scholar
  28. 28.
    Kim, Y., Lim, H. K., Rhim, H., Lee, M. W., Choi, D., Lee, W. J., … Yoo, B. C. (2013). Ten-year outcomes of percutaneous radiofrequency ablation as firstline therapy of early hepatocellular carcinoma: Analysis of prognostic factors. Journal of Hepatology, 58(1), 89–97. https://doi.org/10.1016/j.jhep.2012.09.020.CrossRefGoogle Scholar
  29. 29.
    Kang, T. W., Rhim, H., Lee, M. W., Kim, Y., Choi, D., Lee, W. J., & Lim, H. K. (2011). Radiofrequency Ablation for Hepatocellular Carcinoma Abutting the Diaphragm: Comparison of Effects of Thermal Protection and Therapeutic Efficacy. American Journal of Roentgenology, 196(4), 907–913. https://doi.org/10.2214/AJR.10.4584.CrossRefGoogle Scholar
  30. 30.
    Teratani, T., Yoshida, H., Shiina, S., Obi, S., Sato, S., Tateishi, R., … Omata, M. (2006). Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology, 43(5), 1101–1108. https://doi.org/10.1002/hep.21164.CrossRefGoogle Scholar
  31. 31.
    Nakagomi, R., Tateishi, R., Shiina, S., Imamura, J., Fujiwara, N., Asaoka, Y., … Koike, K. (2014). Drastically Reduced Neoplastic Seeding Related to Radiofrequency Ablation for Hepatocellular Carcinoma. The American Journal of Gastroenterology, 109(5), 774–776. https://doi.org/10.1038/ajg.2014.42.CrossRefGoogle Scholar
  32. 32.
    Lin, C.-C., Cheng, Y.-T., Chen M, W.-T., & Lin, S.-M. (2015). The Effectiveness of Multiple Electrode Radiofrequency Ablation in Patients with Hepatocellular Carcinoma with Lesions More than 3 cm in Size and Barcelona Clinic Liver Cancer Stage A to B2. Liver Cancer, 5(1), 8–20. https://doi.org/10.1159/000367755.CrossRefGoogle Scholar
  33. 33.
    Liu, Y., Zheng, Y., Li, S., Li, B., Zhang, Y., & Yuan, Y. (2013). Percutaneous microwave ablation of larger hepatocellular carcinoma, 68(1). https://doi.org/10.1016/j.crad.2012.05.007.CrossRefGoogle Scholar
  34. 34.
    Shibata, T., Isoda, H., Hirokawa, Y., Arizono, S., Shimada, K., & Togashi, K. (2009). Small Hepatocellular Carcinoma: Is Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization More Effective than Radiofrequency Ablation Alone for Treatment? Radiology, 252(3), 905–913. https://doi.org/10.1148/radiol.2523081676.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of RadiologyUniversity Hospital RegensburgRegensburgGermany

Personalised recommendations